In this study, everyone receives a medicine called EVOLVE104 through an IV, which means it goes into a vein. This is an open label study, so everyone knows the drug and dose they are getting. Each infusion takes about one hour, and doctors will watch you closely during the infusion and for up to two days after it, especially at the beginning. The first three doses are given one week apart. After that, the doses are given every week or every two weeks in 28 day cycles. Early doses may require staying in the hospital overnight and may start at a lower amount that increases slowly to help your body adjust. During the study, you will have regular checkups, blood tests, heart tests, scans every eight weeks, and eye exams. The study has different stages, including screening, treatment, end of treatment, and long term follow up. Screening can last up to 28 days and includes exams, blood tests, heart tests, eye exams, and scans to make sure you can join the study.